268 related articles for article (PubMed ID: 23912992)
1. Adeno-associated viruses as liver-directed gene delivery vehicles: focus on lipoprotein metabolism.
Lagor WR; Johnston JC; Lock M; Vandenberghe LH; Rader DJ
Methods Mol Biol; 2013; 1027():273-307. PubMed ID: 23912992
[TBL] [Abstract][Full Text] [Related]
2. AAV6 Vector Production and Purification for Muscle Gene Therapy.
Halbert CL; Allen JM; Chamberlain JS
Methods Mol Biol; 2018; 1687():257-266. PubMed ID: 29067669
[TBL] [Abstract][Full Text] [Related]
3. Liver-directed gene expression using recombinant AAV 2/8 vectors--a tolerogenic strategy for gene delivery?
Sharland A; Logan GJ; Bishop A; Alexander IE
Discov Med; 2010 Jun; 9(49):519-27. PubMed ID: 20587341
[TBL] [Abstract][Full Text] [Related]
4. Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's disease.
Janelidze S; Nordström U; Kügler S; Brundin P
J Gene Med; 2014; 16(9-10):300-8. PubMed ID: 25303717
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated viral vectors for correction of inborn errors of metabolism: progressing towards clinical application.
Jacobs F; Wang L
Curr Pharm Des; 2011; 17(24):2500-15. PubMed ID: 21774772
[TBL] [Abstract][Full Text] [Related]
6. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
Lu Y
Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
[TBL] [Abstract][Full Text] [Related]
7. Persistent liver expression of murine apoA-l using vectors based on adeno-associated viral vectors serotypes 5 and 1.
Kitajima K; Marchadier DH; Burstein H; Rader DJ
Atherosclerosis; 2006 May; 186(1):65-73. PubMed ID: 16099465
[TBL] [Abstract][Full Text] [Related]
8. Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo.
Gao G; Qu G; Burnham MS; Huang J; Chirmule N; Joshi B; Yu QC; Marsh JA; Conceicao CM; Wilson JM
Hum Gene Ther; 2000 Oct; 11(15):2079-91. PubMed ID: 11044910
[TBL] [Abstract][Full Text] [Related]
9. Vectrology of adeno-associated viruses (AAV).
Skubis-Zegadło J; Stachurska A; Małecki M
Med Wieku Rozwoj; 2013; 17(3):202-6. PubMed ID: 24296444
[TBL] [Abstract][Full Text] [Related]
10. Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus.
Kaspar BK; Roth DM; Lai NC; Drumm JD; Erickson DA; McKirnan MD; Hammond HK
J Gene Med; 2005 Mar; 7(3):316-24. PubMed ID: 15515115
[TBL] [Abstract][Full Text] [Related]
11. [Adeno-associated viral vectors: methods for production and purification for gene therapy applications].
Mena-Enriquez M; Flores-Contreras L; Armendáriz-Borunda J
Rev Invest Clin; 2012; 64(5):487-94. PubMed ID: 23544311
[TBL] [Abstract][Full Text] [Related]
12. Adeno-associated viral vectors for gene therapy of inherited retinal degenerations.
Flannery JG; Visel M
Methods Mol Biol; 2013; 935():351-69. PubMed ID: 23150381
[TBL] [Abstract][Full Text] [Related]
13. Gene delivery to the juvenile mouse liver using AAV2/8 vectors.
Cunningham SC; Dane AP; Spinoulas A; Logan GJ; Alexander IE
Mol Ther; 2008 Jun; 16(6):1081-8. PubMed ID: 18414478
[TBL] [Abstract][Full Text] [Related]
14. microRNA122-regulated transgene expression increases specificity of cardiac gene transfer upon intravenous delivery of AAV9 vectors.
Geisler A; Jungmann A; Kurreck J; Poller W; Katus HA; Vetter R; Fechner H; Müller OJ
Gene Ther; 2011 Feb; 18(2):199-209. PubMed ID: 21048795
[TBL] [Abstract][Full Text] [Related]
15. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
16. Preliminary evaluation of a self-complementary AAV2/8 vector for hepatic gene transfer of human apoE3 to inhibit atherosclerotic lesion development in apoE-deficient mice.
Osman E; Evans V; Graham IR; Athanasopoulos T; McIntosh J; Nathwani AC; Simons JP; Dickson G; Owen JS
Atherosclerosis; 2009 May; 204(1):121-6. PubMed ID: 18930458
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Potency Assay for Adeno-Associated Virus-Based Gene Therapy Vectors Using AAVrh.10 as an Example.
De BP; Chen A; Salami CO; Van de Graaf B; Rosenberg JB; Pagovich OE; Sondhi D; Crystal RG; Kaminsky SM
Hum Gene Ther Methods; 2018 Jun; 29(3):146-155. PubMed ID: 29706115
[TBL] [Abstract][Full Text] [Related]
18. Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates.
Gao G; Lu Y; Calcedo R; Grant RL; Bell P; Wang L; Figueredo J; Lock M; Wilson JM
Mol Ther; 2006 Jan; 13(1):77-87. PubMed ID: 16219492
[TBL] [Abstract][Full Text] [Related]
19. Transient expression of genes delivered to newborn rat liver using recombinant adeno-associated virus 2/8 vectors.
Flageul M; Aubert D; Pichard V; Nguyen TH; Nowrouzi A; Schmidt M; Ferry N
J Gene Med; 2009 Aug; 11(8):689-96. PubMed ID: 19455564
[TBL] [Abstract][Full Text] [Related]
20. Adeno-associated viral vectors for gene transfer and gene therapy.
Büeler H
Biol Chem; 1999 Jun; 380(6):613-22. PubMed ID: 10430026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
